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ABSTRACT
With growing use for hyperthermia as a cardiovascular therapeutic, there is surprisingly little
information regarding the acute effects it may have on the integrity of the neurovascular unit
(NVU). Indeed, relying on animal data would suggest hyperthermia comparable to levels attained
in thermal therapy will disrupt the blood- brain barrier (BBB) and damage the cerebral
parenchymal cells. We sought to address the hypothesis that controlled passive hyperthermia is
not sufficient to damage the NVU in healthy adults. Eleven young men (age 23 ± 3 years)
underwent acute passive heating until +2°C or absolute esophageal temperature of 39.5°C. The
presence of BBB opening was determined by trans-cerebral exchange kinetics (radial-arterial and
jugular venous cannulation) of S100B. Neuronal parenchymal damage was determined by the
trans- cerebral exchange of tau protein, neuron specific enolase (NSE) and neurofilament-light
protein (NF-L). Cerebral blood flow to calculate exchange kinetics was measured by duplex
ultrasound of the right internal carotid and left vertebral artery. Passive heating was performed via
warm-water perfused suit. In hyperthermia, there was no increase in the cerebral exchange of
S100B (p=0.327), tau protein (p=0.626), NF-L (p=0.447) or NSE (p=0.908) suggesting +2°C core
temperature is not sufficient to acutely stress the NVU in healthy men. However, there was a
significant condition effect (p=0.028) of NSE, corresponding to a significant increase in arterial
(p=0.023) but not venous (p=0.173) concentrations in hyperthermia, potentially indicating extracerebral release of NSE. Collectively, results from the present study support the notion that in
young men there is little concern for NVU damage with acute hyperthermia of +2°C.
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CHAPTER 1: BACKGROUND

INTRODUCTION

Hyperthermia can be defined as an increase in core temperature above the normal level (i.e.,
>37.5C), and is on a continuum of mild (≤1.0C), moderate (1.0 to 1.5C), and severe (≥1.5C)
increases in core temperature (Bain et al., 2015). Hyperthermia can also be classified into three
distinct etiologies: febrile (i.e., a fever), passive (i.e., external heating), or exertional (i.e., exerciseinduced) (Bain et al., 2015). Regardless of the etiology, hyperthermia exceeding a core temperature
of 40C is generally associated with a negative sequala of heat-induced cellular damage and a proinflammatory state that can result in life-threatening heatstroke (Epstein & Yanovich, 2019).
However, in non- pathological conditions, hyperthermia not exceeding 40C has gained recent
attention for its tenable therapeutic properties. The aim of this literature review is to outline the
basic origins of heat therapy, with emphasis on the role of hyperthermia for cerebrovascular
regulation.

HYPERTHERMIA AS THERAPY

Cardiovascular diseases (CVDs) are a leading cause of death globally, increasing the need for
novel therapeutic measures (Cardiovascular diseases (CVDs), 2017). Treatment of various
illnesses through heat, in the form of a ‘fever’, has been utilized for centuries (Bierman,1942).
However, owing to recent epidemiology studies (Laukkanen, Khan, Zaccardi, & Laukkanen, 2015;
Laukkanen, Laukkanen, Khan, Babar, & Kunutsor, 2018; Laukkanen et al., 2019), the therapeutic
use of passive heat stress for CVDs has recently gained attention (Cheng & MacDonald, 2019;
Gibbons, Thomas, & Wilson, 2020). It has been well established that endothelial dysfunction
precedes the pathogenesis of several CVDs, such as atherosclerosis (Cheng & MacDonald, 2019).
Interestingly, passive heat stress has been shown to improve vascular health, specifically through
enhanced endothelial function and reductions in arterial stiffness (Cheng & MacDonald, 2019;
Bain et al., 2017; Kunutsor et al., 2018b; Heinonen & Laukkanen, 2018; Laukkanen et al., 2017;
Brunt, Howard, Francisco, Ely, & Minson, 2016a).
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Given these findings, heat therapy has been suggested as a potential alternative to exercising for
individuals who are unable to engage in physical activity (Cheng & MacDonald, 2019; Thomas et
al., 2017). Accordingly, heat therapy can potentially contribute to reducing the burden of CVDs
(Cheng & MacDonald, 2019; Raven & Romero, 2020).

Heat therapy is commonly implemented through the use of Finnish saunas, Waon therapy, and hotwater immersion (Cheng & MacDonald, 2019). Waon therapy is a method of thermal therapy that
involves whole-body heating for 15 minutes in a 60°C sauna until an increase in core temperature
of 1.0-1.2°C, this temperature is then maintained for 30 minutes via bed rest and a warm blanket
(Ohori et al., 2012; Kihara et al., 2009). Waon therapy has been shown to improve symptoms
(Kihara et al., 2009), endothelial and cardiac function, and exercise tolerance, in patients with
chronic heart failure (Ohori et al., 2012). Additionally, it has been shown to improve myocardial
perfusion in patients with chronic total occlusion of the coronary arteries (Sobajima et al., 2013),
as well as reduce pain scores and increase walking distance in patients with peripheral arterial
disease (PAD) (Shinsato et al., 2010). Similar to Waon therapy, heat therapy in the form of hotwater immersion has also been shown to reduce symptoms and improve lower-limb perfusion
(Thomas, van Rij, Lucas, & Cotter, 2017), as well as reduce blood pressure (BP) and walking
distance in patients with PAD (Akerman et al., 2019). Moreover, Green et al., (2010) and Chiesa
et al., (2016) have demonstrated that hot-water immersion improves vascular function through
beneficial changes in shear stress (i.e., a beneficial shear pattern of red blood cells moving across
the luminal side of the endothelium). Lastly, hot-water immersion has been shown to improve
vascular function through reductions in arterial stiffness and improve endothelial function (Brunt et
al., 2016a), and can protect against ischemic- reperfusion injury in the forearm (Brunt et al., 2016b)
and lower limbs (Engelland, Hemingway, Tomasco, Olivencia-Yurvati, & Romero, 2020).

Similar to Waon therapy and hot water immersion, regular use of Finnish saunas has been shown
to improve cardiovascular and peripheral arterial function through reductions in BP and improved
arterial compliance (Lee et al., 2017; Laukkanen et al., 2017; Gravel et al., 2020), and reduced risk
of hypertension (Zaccardi et al., 2017). Furthermore, Finnish sauna use is associated with enhanced
cardiac autonomic nervous function through favourable adjustments to heart rate (HR) variability
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(Laukkanen et al., 2019), reduced risk of sudden cardiac death, fatal cardiovascular diseases, fatal
coronary heart disease, and all-cause mortality (Laukkanen et al., 2015). Interestingly, regular
sauna bathing has also been associated with a reduced risk of Alzheimer’s disease and dementia
(Laukkanen, Kunutsor, Kauhanen, & Laukkanen, 2016). Although the exact mechanism is
unknown, it is postulated to be related to improvements in cerebrovascular endothelial function
and subsequent reductions in inflammation (Laukkanen et al., 2016). However, as discussed
below, heat stress is generally associated with acute increases in cerebral inflammation.

CEREBROVASCULAR REGULATION IN HEAT STRESS

Although there is an abundance of evidence suggesting that heat therapy is an effective
cardiovascular therapeutic, it has yet to be determined if these aforementioned benefits apply to
the cerebral vasculature. The derived benefits of passive heat stress to the peripheral vasculature
is often assumed to apply to the cerebrovasculature, (Caldwell et al., 2020; Gibbons et al., 2020;
Raven & Romero, 2020), however, the peripheral vasculature and cerebral vasculature vary in
response to hyperthermic stress, as evidenced by the differing patterns of blood flow. Indeed, heat
exposure to the peripheral vasculature induces increased anterograde shear (i.e., forward-moving
blood flow) (Green et al., 2010), whereas whole-body hyperthermia greater than 1.0°C results in
reduced anterograde shear in the cerebral vasculature (Bain et al., 2013). This is significant
considering that anterograde shear stress is understood to be beneficial to endothelial function,
whereas retrograde (Cheng et al., 2019) and oscillatory shear stress have been shown to negatively
impact the endothelium (Tremblay, Stimpson, & Pyke, 2019; Tremblay, Thom, Yang, & Ainslie,
2016; Jenkins et al., 2013). Indeed, an increase in core body temperature of 1°C will induce a
reduction in middle cerebral artery velocity of ~10-15% (Bain et al., 2013). This reduction in
cerebral blood flow (CBF) is primarily a result of heat-induced hyperventilation and subsequently
decreased partial pressure of arterial carbon dioxide (PaCO2) that causes cerebral vasoconstriction
(Bain et al., 2015; Low et al., 2008; Low et al., 2009; Ogoh et al., 2013; Nelson et al., 2011; Sharma
& Hoopes, 2013; Caldwell et al., 2020), and secondly a reduced cerebral perfusion pressure from
moderate decreases in arterial pressure (Bain et al., 2015). In fact, severe heat stress, in some, can
elicit a decrease in PaCO2 below 20mmHg which leads to a drastic decrease in CBF and symptoms
such as nausea and tetany (Bain et al., 2015). This response is exacerbated with an increase in core
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temperature of >2°C; the extensive reduction in CBF can result in localized cerebral ischemia and
subsequent increases in cerebral inflammation — a response associated with heatstroke (Bain et
al., 2015). Moreover, there is a concern of severe heat stress as temperatures encroach 40°C.
Heatstroke occurs at core temperatures >40°C and is loosely characterized by central nervous
system (CNS) damage, cerebral edema, and inflammation (Sharma & Hoopes, 2013; Bain et al.,
2015; Bouchama & Knochel, 2002; Sharma, Duncan, & Johanson, 2006). Furthermore, heatstroke
can lead to neuronal injury that may not be detectible until a few days after exposure, and can
potentially result in irreversible cellular death at core temperatures exceeding 42°C (Bain et al.,
2015). Core temperatures >40°C can have a cytotoxic effect on the brain, as the heat exposure can
provoke a pro-inflammatory and pro- coagulative environment (Bain et al., 2015). This is
especially true for the neurovascular unit (NVU) — collectively made up of the cerebral
endothelial, neuronal, and glial cells (Kiyatkin & Sharma, 2009).

NEUROVASCULAR UNIT & BLOOD-BRAIN BARRIER

A particular concern is the implications of passive heat stress to the NVU. The NVU consists of
astrocytes, pericytes, a neuron, endothelial cells, and associated blood-brain barrier (BBB) tight
junctional proteins (Phillips, Chan, Zheng, Krassioukov, & Ainslie, 2015; Hawkins & Davis,
2005). The cerebrovascular endothelial cells, along with transmembrane proteins in the tight
junctions (TJs) between the cells, the pericytes that support the TJs, and surrounding astrocytes
form a semipermeable barrier that regulates paracellular diffusion between the cerebral vessels and
the brain – termed the BBB (Profaci, Munji, Pulido, & Daneman, 2020; Hawkins & Davis, 2005;
Watson et al., 2006; Lu, Chen, Huang, Wang, & Yang, 2004; Sharma & Johanson, 2007; Watson
et al., 2004; Sharma & Sharma, 2007). The BBB is integral to the regulation of the brain milieu
and protecting neuronal parenchyma (Hawkins & Davis, 2005; Profaci et al., 2020; Lu et al., 2004).
This barrier highly restricts the diffusion of large (>400-500 Da) or polar, hydrophilic molecules,
whereas passive diffusion of small, lipid-soluble, nonpolar molecules is unrestricted (e.g., CO2 and
O2) (Profaci et al., 2020; Bain et al., 2015; Lu et al., 2004; Sharma & Johanson, 2007). The essential
molecules such as glucose, vitamins, amino acids, peptides, and electrolytes cross the BBB via
carrier-mediated transport (Watson et al., 2004).
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Although the exact mechanisms are not well understood, it is widely accepted that damage to the
BBB is present in several neurological conditions, such as multiple sclerosis, traumatic brain
injuries (TBIs), stroke, Alzheimer’s disease, bacterial meningitis, and epilepsy (Profaci et al.,
2020; Lu et al., 2004; Watson et al., 2004). In these pathological conditions, it is the systemic
inflammation that is primarily thought to impact the BBB by compromising the TJs (Hawkins &
Davis, 2005), leading to increased BBB permeability and consequent cerebral edema and increased
intracranial pressure (ICP) (Chupel et al., 2018; Lu et al., 2004; Bain et al., 2015; Sharma,
Zimmermann-Meinzingen, & Johanson, 2010). Importantly, while pro-inflammatory cytokines
(e.g., IL-6) are upregulated in heat stress (Bouchama & Knochel, 2002), damage to the
endothelium and BBB may also be exacerbated through dehydration (Bain et al., 2015) and
increased nitric oxide (NO) production that occurs through hyperthermia (Sharma, Drieu, Alm, &
Westman, 2000).

Hyperthermia is associated with poor outcomes when experienced in patients after suffering a TBI
(Bain et al., 2020; Thompson et al., 2003). Even a mild increase in core temperature of 1°C is
enough to contribute to secondary brain damage and worsened neurological outcomes in patients
who have had a TBI (Bonds et al., 2015). This is particularly evident in rats exposed to mild heat
stress (≤ 1°C) post-TBI; a 1°C increase in core temperature was associated with BBB disruption,
accelerated neurological damage, elevated free radical production, and increased inflammation
(Bonds et al., 2015). Interestingly, rats exposed to 4h of heat stress at an ambient temperature of
38°C had a marked increase in BBB permeability, meanwhile, no increase in permeability was
detected in rats only exposed to heating for 1 or 2h (Sharma & Hoopes, 2013; Sharma & Johanson,
2007). Moreover, the breakdown of the BBB leads to heat-induced cerebral edema and consequent
increased ICP (Sharma & Hoopes, 2013; Bain et al., 2015). However, it is worth noting that rats
are not as equipped as humans to handle the physiological stressors of hyperthermia (Bain et al.,
2015).

Despite the potential negative impacts of heat stress on the NVU as detailed above, controlled
hyperthermia may in fact help to prevent both inflammatory and oxidative stress (Brunt,
Wiedenfeld-Needham, Comrada, & Minson, 2018). This may, in part, be related to the
upregulation of heat shock proteins (HSPs), as they are involved in the activation of anti- oxidative
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and anti-inflammatory proteins (Brunt et al., 2018; Brunt et al., 2016a). Interestingly, Bain et al.,
(2017) demonstrated that an acute bout of heat stress, until an increase of 2°C in core temperature
(~39.5°C), reduced circulating microparticles that are established biomarkers of vascular
dysfunction, and is not sufficient to produce an excessive pro-oxidative or pro- inflammatory
response (Bain et al., 2020). Thus, indicating a potential benefit to severe passive heating to +2°C
core temperature (Bain et al., 2017). Furthermore, HSPs may also be involved in protecting the
BBB from damage through the preservation of TJ proteins due to their role in refolding denatured
proteins (Lu et al., 2004; Thompson et al., 2003). Thus, suggesting that HSPs could potentially be
integral to the maintenance of cerebrovascular functioning during heat stress through BBB
integrity (Lu et al., 2004). Potential benefits of heat stress on the cerebrovascular may also result
from the transient increases in the cerebral metabolic rate of O2 (CMRO2) which, in turn, can
improve immune function (Bain et al., 2020). Indeed, an elevated core temperature of +1.5C to
+2.0C elicits a ~20% increase in CMRO2, owing to the increased activity metabolic enzymes
(namely phosphofructokinase) as a result of the hyperthermia (Bain et al., 2020). However, the
change in metabolic rate may be influenced by neural activity (Bain et al., 2020).

Circulating

Cerebral

NVU

Figure 1. Continuum of major cerebrovascular impacts with progressive heat stress. An increase
in core temperature exceeding 1°C is known to cause progressive reductions in cerebral blood
6

flow (CBF) and anterograde shear via hyperventilation induced hypocapnia and secondly reduced
cerebral perfusion pressure (CPP). The cerebral metabolic rate of oxygen (CMRO 2) is
progressively increased related to the Q10 effect for biological tissue. The temperature at which
extensive blood-brain barrier (BBB) opening and damage to the neurovascular unit (NVU) occurs,
thus leading to pathological damage, is unknown. See text for details.

STUDY RATIONALE AND HYPOTHESIS

Given that hyperthermia of up to +2°C core temperature [i.e., during hot yoga, Finnish sauna or
Waon therapy (Cheng & MacDonald, 2019)] has gained widespread attention as a tool to improve
cardiovascular function, there is a need to confirm that this level of heating is safe for the NVU in
humans. Accordingly, the purpose of this study was to determine the trans- cerebral arterial-venous
kinetics of S100B (an established marker of BBB permeability) in passive hyperthermia, as well
as concurrent biochemical metrics of the NVU function as indexed by an established clinical panel
for cerebral damage; tau protein, neuron-specific enolase (NSE) and neurofilament-light protein
(NF-L) (Kanner et al., 2003; Topolovec-Vranic et al., 2011; Wang et al., 2018).

Based on previous observations by Bain text al., (2020) that passive hyperthermia does not evoke
a robust increase in the cerebral release of inflammatory and pro-oxidative markers in humans (a
tenable mechanism for BBB opening), we hypothesized that acute passive hyperthermia of +2°C
core temperature in healthy young men would not elicit marked BBB opening as determined by
the trans-cerebral release of S100B, or detectable cerebral parenchymal damage determined by
the release of tau protein, NSE, and NF-L.
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CHAPTER 2: METHODOLOGY

SUBJECTS AND ETHICAL APPROVAL

Eleven healthy young men (age 23 ± 3 years) participated in the study. As a result of the
experimental setup, study requirements, and optimal neck anatomy for ultrasound measures, the
participants chosen were all males. Additionally, it is known that the menstrual cycle can impact
thermoregulatory responses, and we were limited to a short physician schedule to insert the
catheters. Thus, controlling for menstrual cycle was not possible. All subjects were non-obese
(body mass index 23.0 ± 2.1 kg/m2), normotensive (118/71 ± 6/7 mmHg), normoglycemic (<7.0
mmol/L), non-smoking and free of overt cardiometabolic and respiratory disease (all variables are
mean ± SD). All experimentation was completed at the Centre for Heart, Lung & Vascular Health,
University of British Columbia, Kelowna, BC, Canada. The ethical committee of the University
of British Columbia approved the study (H15-00166). The study conformed to the standards set
by the Declaration of Helsinki, except registry in a database. All subjects provided informed
written consent before experimentation. Subset measures from this study have been published
elsewhere under separate experimental questions relating to circulating microvesicles (Bain et al.,
2017), and cerebral metabolism (Bain et al., 2018). The present study encompasses separate apriori hypotheses.

EXPERIMENTAL PROTOCOL

Subjects arrived at the laboratory after a 4 to 12 hr fast and minimum 12 hr abstinence from alcohol
and caffeine-containing beverages. Upon arrival, participants were immediately assessed for
adequate (≤1.020) hydration, via urine specific gravity (model TS 400, Reichert Analytical
Instruments, Depew, NY). Under local anaesthesia (1% lidocaine) and ultrasound guidance, a 20gauge arterial catheter (Arrow, Markham, ON, Canada) was placed inthe right radial artery, and a
central venous catheter (Edwards PediaSat Oximetry Catheter, CA, USA) was placed in the right
internal jugular vein and advanced towards the jugular bulb. Following cannulation, subjects were
fitted into a tube-lined suit (Med-Eng, Ottawa, ON, Canada) that covered the entire body except for
the head, feet and hands. The tube-lined suit was perfused with ~49°C water until an esophageal
temperature of +2°C above baseline, an absolute core temperature of 39.5°C, or the subject's
8

volitional thermal tolerance was reached. Core temperature (Teso) was determined by a
thermocouple probe (RET-1; Physitemp Instruments, Clifton, NJ, USA) that was inserted 40 cm
past the nostril into the esophagus. Blood samples were collected into vacutainers containing
ethylenediaminetetraacetic acid (EDTA) for separation of plasma and quantification of tau, as well
as tubes containing no anticoagulant for analysis of S100B, NSE and NF-L. Samples were collected
simultaneously from the radial artery and jugular bulb immediately before heating (normothermic)
and at +2°C core temperature. A time- control group was not incorporated into the experimental
design given previous reports demonstrating no time effect of the cross-brain measures (Bain et al.,
2016; Bain et al., 2018).

CARDIOVASCULAR AND CEREBROVASCULAR MEASURES

Blood flow in the right internal carotid artery (ICA) and left vertebral artery (VA) was
simultaneously measured using duplex vascular ultrasound (Terason 3200, Teratech, Burlington,
MA), and used to calculated global cerebral blood flow; (ICA x 2) + (VA x 2). The right ICA was
on average insonated 2cm from the carotid bifurcation, while the left VA was insonated at the C5–
C6 or C4–C5 space depending on the subject’s unique anatomy. The steering angle was fixed to
60 degrees for all measures, and the sample volume was placed in the center of the vessel adjusted
to cover the entire vascular lumen. All files were screen-captured and saved as video files for
offline analysis at 30Hz using custom-designed software (Woodman et al., 2001). Simultaneous
measures of luminal diameter and velocity over a minimum of 12 cardiac cycles were used to
calculate blood flow. The within-day coefficient of variation for the ICA (sonographer: co-author
R.L.H.) and VA (sonographer: co-author A.R.B.) blood flow was 7% and 4%, respectively. Heart
rate (HR) was obtained from the R-R intervals measured in lead II of the ECG. Mean arterial blood
pressure (MAP) was measured with a pressure transducer connected to the radial catheter.

NVU BIOMARKER ANALYSIS

Serum S100B and plasma NSE concentrations were measured using commercially available
immunoassays with electrochemiluminescence detection on Cobas according to instructions from
the manufacturer (Roche Diagnostics, Penzberg, Germany). Serum NF-L concentration was
measured on a Single molecule array (Simoa) HD-1 Analyzer using the commercially available
9

NF-Light kit according to instructions from the manufacturer (Quanterix, Billerica, MA). Plasma
tau concentration was measured on a Simoa HD-1 Analyzer using the commercially available Tau
Advantage kit according to instructions from the manufacturer (Quanterix, Billerica, MA).
All measurements were performed in one round of experiments using one batch of reagents by
board-certified laboratory technicians who were blinded to clinical data. Intra-assay coefficients
of variation were 3-5% for S100B and NSE, 7.2% for NF-L and 11% for tau. Cerebral exchange
was calculated as the global cerebral blood flow x the arterial-venous difference of each respective
biomarker, whereby a negative value denotes cerebral release.

RATIONALE FOR BIOMARKERS USED

S100B

S100B is a calcium-binding protein that has a low molecular weight and is predominantly
expressed in glial cells in the CNS, with the majority located in the end-feet of astrocytes (Watson
et al., 2004; Bain et al., 2015; Topolovec-Vranic et al., 2011; Neselius et al., 2012; Wang et al.,
2018; Schulpis et al., 2007; Kanner et al., 2003; Chupel et al., 2018; Koh & Lee, 2014; Tubaro,
Arcuri, Giambanco, & Donato, 2010). Due to the close proximity of the astrocyte end-feet to the
cerebral blood vessels, S100B is freely released into the cerebral circulation if the permeability of
the BBB is increased (Bain et al., 2015; Cheuvront et al., 2008) and, for this reason, it is the most
commonly used biomarker for BBB damage (Watson et al., 2004; Koh & Lee, 2014). Granted,
small amounts of S100B can also be found in extra-cerebral locations, including the heart, muscle,
adipose tissue, GI tract, and bone (Watson et al., 2006; Buonora et al., 2015; Wang et al., 2018;
Cheuvront et al., 2008; Schulpis et al., 2007; Koh & Lee, 2014), and serum S100B concentrations
have been shown to moderately increase following acute bouts of exercise (Cheuvront et al., 2008;
Schulpis et al., 2007), potentially indicating a transient release from contracting skeletal muscle.
However, the serum concentration of this protein in healthy individuals is typically minuscule and
is therefore considered a reliable indicator of compromised BBB integrity (Watson et al., 2004;
Cheuvront et al., 2008; Kanner et al., 2003; Chupel et al., 2018). Interestingly, prolonged exercise
in a warm environment may increase BBB permeability and can be detected by measuring
concentrations of serum S100B, comparable to passive heat stress (Watson, Shirreffs, & Maughan,
2005). This may be due to the stress placed on the BBB during prolonged exercise, as there may
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be transient increases in permeability as a result of endothelial cell shrinkage and therefore
widened gaps between the cells, allowing an influx and efflux of substances that normally would
be restricted from paracellular diffusion (Watson, Black, & Maughan, 2006). This reduced BBB
integrity has also been shown to occur in rats subjected to exercise in a hyperthermic environment
(Watson et al., 2005).

Increased serum levels of S100B are associated with poor patient outcomes and neurological
damage when serum concentrations are greatly elevated (Watson et al., 2004; Wang et al., 2018;
Kanner et al., 2003). Specifically, elevated levels of this protein have been correlated with
increased cerebral damage in post-stroke patients (Anderson et al., 2001), after subarachnoid
hemorrhaging, and TBIs (Kanner et al., 2003; Wang et al., 2018). Interestingly, heightened serum
S100B is also associated with neurodegenerative diseases, such as Alzheimer’s disease and
Parkinson’s Disease (Chupel et al., 2018). S100B has also been shown to increase following TBIs
and is associated with poor clinical outcomes, specifically in boxers (Shahim et al., 2016; Neselius
et al., 2012), hockey players (Shahim et al., 2014), and soldiers (Topolovec-Vranic et al., 2011).
Furthermore, in rats subjected to TBIs through blast trauma, serum S100B was significantly
elevated, indicating a compromised BBB (Liu et al., 2015).

NEURON-SPECIFIC ENOLASE (NSE)

NSE is a glycolytic enzyme in neurons and neuroendocrine cells with typically low baseline
expression that is upregulated only during neuronal stress. An increase in circulating NSE is, in
turn, a recognized indicator of neuronal damage (Topolovec-Vranic et al., 2011; Isgrò, Bottoni, &
Scatena, 2015; Chupel et al., 2018; Haque, Polcyn, Matzelle, & Banik, 2018; Schmechel,
Marangos, & Brightman, 1978; Wang et al., 2018; Polcyn et al., 2017). Although the exact role
requires further investigation, NSE is involved in the neuroinflammatory response following
neuronal injury and is thus considered a highly specific biomarker (Haque et al., 2018; Jouffroy et
al., 2019). Similar to S100B, upregulation of NSE is also associated with TBIs, stroke,
neurodegenerative diseases, in addition to cardiac arrest, lung cancer, seizures, neuroblastoma,
spinal cord injuries, and ischemia-reperfusion injury (Polcyn et al., 2017; Isgrò et al.,2015).
Moreover, NSE is clinically used as a quantitative measure of the severity of brain damage, and to
determine prognosis in patients who have suffered from an ischemic stroke, seizures, cardiac
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arrest, TBI, or intracerebral hemorrhage (Isgrò et al., 2015; Haque et al., 2018). Specific to
neurodegenerative disorders, elevated NSE is correlated with the level of disability and severity of
neurological deficits (Haque et al., 2018).

NEUROFILAMENT-LIGHT PROTEIN (NF-L)

NF-L is a scaffolding protein that is entirely specific to neurons and is primarily expressed in
axonal white matter (Wang et al., 2018; Shahim et al., 2016). Due to its location, elevated
concentrations of NF-L are used as a biomarker of axon degeneration (Neselius et al., 2012; Wang
et al., 2012; Shahim et al., 2016; Zetterberg et al., 2006). In fact, NF-L is most commonly used as
a clinical marker for the diagnosis and prognosis of TBIs (Wang et al., 2018; Shahim et al., 2016;
Neselius et al., 2012), as several studies have identified the correlation with upregulated NF-L and
the presence of a cerebral insult, particularly in boxers (Neselius et al., 2012; Zetterberg et al.,
2006).

TAU PROTEIN

Similar to NF-L, tau is a protein that is predominantly located in neuronal axons and provides
stability to microtubules (Neselius et al., 2012; Mandelkow & Mandelkow, 2012; Barbier et al.,
2019; Pîrscoveanu et al., 2017; Rubenstein et al., 2017). Modifications to tau protein structure and
function are characteristic of many neurodegenerative diseases, termed tauopathies (Barbier et al.,
2019; Pîrscoveanu et al., 2017). Moreover, studies investigating the role of tau in brain injuries
and neurodegenerative diseases have shown that concentrations of tau are remarkably increased
following TBIs (Shahim et al., 2016; Wang et al., 2016), specifically in boxers (Neselius et al.,
2012; Zetterberg et al., 2006), hockey players (Shahim et al., 2014), and soldiers (Olivera et al.,
2015). As such, tau is a widely used biomarker of neuronal damage and is frequently used in the
assessment of brain injuries (Neselius et al., 2012; Mandelkow & Mandelkow, 2012; Wang et al.,
2018; Olivera et al., 2015).

STATISTICAL ANALYSIS
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Analyses were performed using the statistical software package SPSS (v.22; IBM, Armonk, NY,
USA). Cerebral blood flow (to calculate cerebral exchange of brain proteins) was averaged over
20- second bins around the blood draws. Tests for normality were confirmed using repeated
Shapiro-Wilks W tests, whereby concentration differences of all four markers at baseline and heat
stress were non-significant (p > 0.05). Statistical analyses for all NVU biomarkers were performed
using 2-way [condition (baseline vs. hyperthermia), and site (arterial vs. venous)] repeatedmeasures ANOVA. After a main effect, post hoc analyses were performed using two tailed
repeated- measures Student’s t-tests. Effect size was calculated as Hedges’ g corrected for a small
sample size using the formula:

Where; mean 1 (M1) is baseline, and mean 2 (M2) is heat stress. Significance was determined at
an alpha level of 0.05. All data are presented as means ± SD.
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CHAPTER 3: RESULTS

THERMOMETRY AND DESCRIPTIVE DATA

Absolute esophageal temperature at baseline was 37.3±0.2ºC, and at peak heat stress was
39.2±0.2ºC. Average heating time (elapsed time between baseline and measures at peak heat stress)
was 58±8 min. Participants were kept at peak heat stress for ~five minutes. Individual core
temperature for baseline and heat stress, as well as cardiovascular and cerebrovascular descriptive
data, is presented in Table 1.

NVU BIOMARKERS

Mean data are presented in Table 2. Individual data are presented in Figure 1, and individual
cerebral exchange data are presented in Figure 2. There were no effects on S100B, tau protein, or
NF-L across condition, site, or condition x site (p all >0.05). However, there was a significant main
effect of heat stress (condition) on NSE (p=0.028), but no significant main effect of site (p=0.910)
or interaction (p=0.908). Post hoc analysis revealed a significant increase in arterial (p=0.023;
Hedges’ g= -0.40) but not venous (p=0.173; Hedges’ g= -0.43) concentrations of NSE from
baseline to heat stress. There were no significant effects of heat stress on the cerebral exchange of
S100B (Hedges’ g= -0.56), NSE (Hedges’ g= -0.14), tau protein (Hedges g= -0.09),or NF-L
(Hedges’ g= -0.12) (p all >0.05).
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Table 1.Baseline and heat stress participant descriptives. Tcore; esophageal temperature. MAP;
mean arterial blood pressure, intra-radial. CBF; cerebral blood flow (duplex ultrasound of the
internal vertebral carotid artery. HR; heart rate from lead II. The participant symbols are consistent
with Figure 2.

Table 2. Mean values ±SD of arterial and venous S100B, NSE, tau protein, and NF-L at baseline
(normothermia) and heat stress (+2 C esophageal temperature). Net exchange s calculated from
the global cerebral blood flow x arterial- venous difference. Condition = baseline vs. heat stress;
Site arterial vs. venous; Condition x Site = interaction.
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Figure 2. Individual values for arterial (gray filled bars) and venous (open bars) S100B (top left),
NSE (top right), NF-L (bottom left), and tau protein (bottom right), at normothermic baseline (BL)
and hyperthermic heat stress (HS). No significant interaction was observed in any variable.
However, there was a significant condition effect (P = 0.028) of NSE, corresponding to a
significant increase in arterial (P = 0.023) but not venous NSE (P = 0.173) from BL to HS. Sample
size = 11 except for S100B where n = 10. Statistical analysis performed by 2-way ANOVA.
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Figure 3. Individual values for cerebral exchange of S100B (top left), NSE (top right), NF-L
(bottom left), and tau protein (bottom right), at normothermic baseline (BL) and hyperthermic heat
stress (HS). Gray filled bars with error bars denoted means ± SD. Negative values denote net
cerebral release; positive values denote uptake. No significant difference between (P > 0.05) was
observed between BL and HS in any measure. Sample size = 11 except for S100B where n = 10.
Statistical analysis performed by 2-way ANOVA and repeated-measures Student’s t-tests when
appropriate.
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CHAPTER 4: DISCUSSION

The primary finding of this study is that marked passive hyperthermia of ~2.0ºC by means of
passive heating is not sufficient to acutely open the BBB or provoke any discernible cerebral
neuronal parenchymal damage in young healthy males. This finding was evidenced by an unaltered
cerebral exchange of S100B, NSE, tau protein, and NF-L. However, heat stress increased
circulating NSE in the arterial circulation, perhaps indicating contribution from non-cerebral
sources.

IS +2ºC CORE TEMPERATURE SAFE FOR THE NVU?

Results of the present study are timely given the recent surge in employing passive heat stress as
a cardiovascular therapeutic (Brunt et al., 2016a; Gravel et al., 2020; Kihara et al., 2009; Kunutsor
et al., 2018; Laukkanen et al., 2015; Laukkanen et al., 2016; Laukkanen et al., 2017; Laukkanen
et al., 2018; Lee et al., 2017; Ohori et al., 2012; Sobajima et al., 2013). In experimental use of
thermal therapy (e.g., sauna use), core temperature elevations of up to 2ºC are often reported
(Laukkanen et al., 2017). While it is generally accepted that induced heat stress should not exceed
an absolute core temperature of ~40ºC [to avoid life-threatening complications of heat illness
(Bouchama et al., 2002)], impetus for the present study relates to the notion that the cerebral tissue
may become damaged at a much lower threshold temperature. For example, with progressive
continuous heating, as employed in the current study, BBB leakage in rats (assessed by stained
albumin and astrocytic activation) begins to occur at 38.5ºC (Kiyatkin et al., 2009). Moreover,
even a 1.0ºC increase in core temperature is problematic for cerebral outcomes in human
conditions of traumatic brain injury (Bonds et al., 2015; Thompson et al., 2003), likely in part
related to increased pro-inflammatory responses. That is, passive heat stress invariably increases
IL-6, a known cytokine that stimulates BBB opening (Brunt et al., 2018; Watson et al., 2006; Bain
et al., 2015), which can induce or exacerbate damage to the NVU (in the setting of TBI) by means
of neuroinflammation, edema, and ionic imbalances (Profaci et al., 2020). Importantly, we have
previously demonstrated that with +2.0ºC core temperature the cerebral exchange of pro-oxidative
and inflammatory markers (oxidative-low density lipoprotein, myeloperoxidase, and IL-6) are not
increased, however, the increase in IL-6 in a sample of six participants trended to selectively
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increase more in the cerebral tissue (Bain et al., 2020). At least in healthy young males, results
from the present study reassure that this trend for increases in cerebral IL-6 does not lend to BBB
opening. (There is an absence of a relationship between jugular venous IL-6 and S100B in heat
stress; r=0.454, p=0.219, unpublished data, n=10). Furthermore, elevated concentrations of IL-6
during the acute-phase immune response may be beneficial due to the upregulation of antioxidant
pathways (Bouchama & Knochel, 2002).

BIOMARKERS FOR NVU DAMAGE; IMPACT OF EXTRACEREBRAL SOURCES?

The primarily astroglial protein S100B was used to quantify BBB leakage (Cheuvront et al., 2008;
Kanner et al., 2003; Watson et al., 2006), while concentrations of the CNS dominant tau protein,
NF-L, and NSE were measured to provide insight on neuronal parenchymal damage. While the
lack of cerebral release or increase in jugular venous concentrations of S100B, tau protein, NF-L
and NSE collectively suggests that passive heat stress up to 39.5ºC core temperature in healthy
young men is not sufficient to acutely increase BBB permeability or damage the cerebral neuronal
parenchyma; the increase in NSE from BL to HS is notable. Because of the lack of cerebral
exchange, this net increase in NSE from baseline to heat stress may be attributed to release from
non-cerebral sources, which is consistent with systemic release of NSE driving a similar average
but highly variable (and therefore non-significant) increase in venous NSE (Figure 2). That is, the
arterial increase in NSE may have carried over to the cerebral venous side in some. For example,
although NSE is most abundant in neurons located in the brain, it is also located in neuroendocrine
tissues throughout the body, specifically the adrenal glands (Haque et al., 2018; Schmechel et al.,
1978). Hyperthermia activates the hypothalamic-pituitary-adrenal axis through feedforward
mechanisms (Koko, 2004; Path et al., 2000), contributing to the heat-induced hyperadrenergic state
(Rowell, 1990). In turn, it has been demonstrated in rats that heat stress acutely decreases adrenal
cortex volume and mass with concomitant increases in circulating corticotrophin and
corticosterone (Koko, 2004). Concentrations of circulating cortisol are also significantly elevated
in heat-stressed humans (Brenner et al., 1998; Collins et al., 1969; Follenius et al., 1982). It is,
therefore, reasonable to suggest that the increase in systemic concentrations of NSE was from
adrenal sources consequent to the profound heat-induced excitation. Regardless of its source,
however, it remains to be determined whether the increase in NSE is an inert bi-product of
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hyperthermia, or a marker of important physiologic function / malfunction. Furthermore, an
important consideration is whether the average increase in NSE of only ~6ng/mL (from ~13 to 19
ng/mL)has physiologic relevance. For comparison, a two-fold increase in NSE (compared to
controls) has been reported in humans less than 48 hrs following mild traumatic brain injury
(Buonora et al., 2015).

EXERCISE, TEMPERATURE & NVU BIOMARKERS

Exercise has been shown to increase the circulating concentration of some CNS-targeted
biomarkers, particularly S100B [reviewed in (Koh & Lee, 2014)]. It is often assumed that the
exercise- induced increase in S100B is indicative of BBB opening and, in part, as a consequence
of the increases in cerebral temperature (Watson et al., 2005) in the absence of physical head
trauma. Results from the present study, however, suggest that temperature alone may have a
negligible impact on circulating S100B from cerebral sources, at least when core temperature does
not exceed ~39.5ºC, and in the absence of head trauma. Several alternative mechanisms may
explain increased circulating concentrations of S100B during exercise (Koh & Lee, 2014). For
example, although S100B is primarily located in the brain, it is also in the skeletal myofibrils,
cardiac muscles, chondrocytes, melanocytes, and adipocytes (Anderson et al., 2001; Gonçalves et
al., 2010; Tubaro et al., 2010; Wang et al., 2018). Indeed, S100B has been shown to positively
correlate with increases in creatine kinase after exercise which is indicative of muscular
degradation (Schulpis et al., 2007). However, Watson et al. (Watson et al., 2005) demonstrated
that peripherally circulating concentrations of S100B is higher during exercise in warm versus cold
conditions at the same workload. While these data certainly indicate hyperthermia as a variable for
the additional release of S100B, it still does not provide insight into its source. That is,
hyperthermic muscle may release more S100B. This notion is consistent with the present study
whereby no increase in S100B is observed in passive hyperthermia, notably with identical
elevations in core temperature to Watson et al., (2005). A similar assumption may be held with
reported increases in NSE during long-distance running (Jouffroy et al., 2019) – that is, increased
circulating concentrations from extra-cerebral sources, which is likely in part temperaturedependent. However, this may also be time- dependent as S100B have been shown to markedly
increase in long-distance runners (Jouffroy et al., 2019). Indeed, it is worth noting that this
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elevation of S100B may be related to the level of clearance from the kidneys (reviewed in Bain et
al., 2015).

CONSIDERATIONS & FUTURE RESEARCH
The data herein must be interpreted solely within the context of the study – an acute setting with
an average heating duration of ~1hr in young healthy adult men. Although these initial results
corroborate the safety of passive heating for the brain, there remain many important areas for future
research. Foremost, future studies should consider differences in sex, age, and in people with comorbidities. This latter group is especially important given the target population for heat therapy
[e.g., heart failure (Gravel et al., 2020; Kihara et al., 2009; Ohori et al., 2012) and peripheral arterial
disease (Akerman et al., 2019; Shinsato et al., 2010; Thomas et al., 2017)]. Another important
consideration is the acute heating stimulus and timing of measurements. In this respect,
concentrations of NF-L should be interpreted with the most caution. Neurofilament proteins are
found exclusively in neurons, which make them ideal markers for CNS injury; however, their
release to the circulation can be delayed by days following the initial injury (Neselius et al., 2012;
Shahim et al., 2016; Wang et al., 2018; Zetterberg et al., 2006). NF-L was included in the present
analysis given the unique setting to address cross-brain kinetics with the potential to observe a
snapshot of increased cerebral release, as opposed to the conventional measures limited to the
peripheral venous circulation. Nonetheless, NF-L is generally classified as a ‘delayed’ axonal
injury marker. On the other hand, both NSE (Buonora et al., 2015; Liu et al., 2015; TopolovecVranic et al., 2011) and tau protein (Olivera et al., 2015; Rubenstein et al., 2017; Shahim et al.,
2014; Yang et al., 2014) are elevated in the acute setting of cerebral injury. We are therefore
confident that, collectively, our measures had the sensitivity to demonstrate cerebral injury in the
present study setting, had it occurred. Still, future studies should consider tracking (at least in the
peripheral venous system) CNS biomarkers over days following the hyperthermic stress. The
duration and rate of the heating stimulus should also be considered, under the premise that longer
heat stress durations (>1 hour) may be necessary for disruption of the BBB (Sharma & Hoopes,
2003; Sharma & Johanson, 2007). Additionally, future studies should consider cross-brain
measures of S100B during steady-state exercise in cold or warm environments, to establish
contribution from extra-cerebral sources. Importantly, future studies should consider a timed
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control group, especially with heating conditions of longer durations. A normothermic time control
group was not attainable in the present study given the invasive experimental setup. However, in
previous studies by Bain et al., (2016; 2018), participants were cannulated for well over six hours
(under varying apneic conditions), and an increase in NSE was not observed. We are confident
that the increase in NSE is therefore related to the hyperthermia, and not a time effect.

Lastly, future research should consider heat shock protein (HSP) analysis. HSPs are involved in
the stabilization and activation of additional proteins that are vital to the cardiovascular system –
namely anti-oxidative and anti-inflammatory proteins, in addition to proteins that improve NO
signaling which, collectively, influence vascular function (Brunt et al., 2016a; Brunt et al., 2018).
Additionally, HSPs are considered to be chaperone molecules that are involved in the refolding or
folding of denatured or misfolded proteins (Lu et al., 2004; Thompson et al., 2003), and are
expressed upon heat exposure (Brunt et al., 2016a). Specifically, the upregulation of HSPs in
response to severe heat stress has been shown to protect against cerebral damage, whereas low
levels of HSPs have been associated with conditions such as aging and lack of heat acclimatization
(Bouchama & Knochel, 2002). This may be due to the involvement of HSPs in the structural
protection of the cytoskeleton and TJ proteins, and thus, maintenance of endothelial cell integrity
(Lu et al., 2004). Accordingly, the analysis of a potential HSP response may have provided insight
into the beneficial role of an acute bout of severe, passive heat stress.
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